You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Optimized lactoferrin for treatment of intracerebral hemorrhage

    SBC: Pharmareview Corporation            Topic: NINDS

    DESCRIPTION provided by applicant Intracerebral hemorrhage ICH is a major public health problem with highest mortality rate of all stroke subtypes and long term disability Since there are no available FDA approved therapies for ICH it is of enormous importance to establish effective treatment for this medical condition Following ICH the deposited blood is damaging initially via compression ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Ovarian cancer using novel nanoparticle formulations

    SBC: KIROMIC BIOPHARMA INC            Topic: 102

    DESCRIPTION provided by applicant Ovarian cancer is the fifth most leading cause of cancer related deaths in women in the US It has been observed that the cancer relapses within relatively short periods of time even after the surgery and chemotherapy Therefore immunotherapeutic strategies may serve as an alternative to control the recurrence or progression of ovarian cancer Oral vaccines ar ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. STTR Phase I: Design of a Handheld Multi-sensor Passive Pulmonary Function Testing Device

    SBC: Cognita Labs, LLC            Topic: SH

    The broader impact/commercial impact of this Small Business Technology Transfer (STTR) Phase I project is development of a pulmonary function testing device for detection and diagnosis of pulmonary conditions. Today more than 650 million globally, nearly 10% of the world?s population, suffers from lung conditions like Asthma and Chronic Obstructive Pulmonary Disease (COPD). Currently, the most wel ...

    STTR Phase I 2014 National Science Foundation
  4. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. New heterocyclic inhibitors of filoviruses

    SBC: MICROBIOTIX, INC.            Topic: H

    DESCRIPTION provided by applicant Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction with an incubation period of days Because of the safety concerns these viruses are designated as the biosafety level agents Currently there is no effective vaccine or therapeutic treatment against filoviral i ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. New small molecule inhibitors of arenaviruses

    SBC: MICROBIOTIX, INC.            Topic: R

    DESCRIPTION provided by applicant Lassa fever virus LASV and Machupo virus MACV are hemorrhagic fever arenaviruses which are classified as Category A Agents Currently there are no licensed LASV or MACV vaccines and LASV MACV therapy is limited to use of the nucleoside analog ribavirin which is only partially effective and associated with significant side effects The impact of arenavirus ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. STTR Phase I: Conversion of Enhanced Copper Foils to Wire Forms

    SBC: NanoRidge Materials            Topic: NM

    This Small Business Technology Transfer Phase I project will substantially advance 1) approaches to combine carbon nanotubes (CNT) into metal matrices, 2) processes to convert copper/CNT composites into wire while preserving CNT integrity, 3) methods to induce CNT alignment during either nanocomposite production or extrusion in order to optimize electrical conductivity, and 4) process control to e ...

    STTR Phase I 2014 National Science Foundation
  8. STTR Phase I: Robotic Leg Advancement Device

    SBC: AndrosRobotics LLC            Topic: EI

    This Small Business Technology Transfer Research (STTR) Phase I project seeks to develop a novel, intelligent device for automation of gait training in the neurological patient population undergoing physical therapy and rehabilitation. The objective of this project is the creation of a physically simple robotic system, which uses a sophisticated control system to intelligently cooperate with the p ...

    STTR Phase I 2014 National Science Foundation
  9. STTR Phase I: Software-Based Building Airflow Analysis Tool for Enabling HVAC Energy Use Savings in Commercial Buildings

    SBC: Aeolus Building Efficiency Inc            Topic: BC

    This Small Business Technology Transfer (STTR) Phase I project will establish proof of concept for a unique, software-based Building Airflow Analysis Tool for measuring and optimizing airflow rates in commercial buildings. Using the existing Building Automation System (BAS), room temperature responses to controlled perturbations of airflow rates are used with a physics-based room thermal model and ...

    STTR Phase I 2014 National Science Foundation
  10. STTR Phase I: Silver Replacement for Conductive Inks

    SBC: Microreactor Solutions LLC            Topic: NM

    This Small Business Innovation Research (SBIR) Phase I project will develop new materials to replace silver in conductive ink applications. Current silver replacement materials all have significant drawbacks making them unsuitable for use in many industries which would benefit from these cost savings. The project will utilize advanced thin film nanocoatings to produce silver replacement materials ...

    STTR Phase I 2014 National Science Foundation
US Flag An Official Website of the United States Government